Le Lézard
Classified in: Health, Science and technology
Subject: Environmental, Social, and Governance Criteria

Feedback Digest from Global Consultation on Ecosystem Restoration Standard

PARIS, June 30, 2023 (GLOBE NEWSWIRE) -- Ecosystem Restoration Standard (ERS) released a summary of the feedback following the successful completion of its public consultation.

Launched on March 21st, ERS public consultation has exceeded expectations, drawing substantial participation from 554 organizations around the globe.

Thibault Sorret, ERS CEO, explains:

"We're thrilled by the response to the public consultation. Not only in the number of responses but also in their depth and quality. We're in the midst of integrating the changes to ensure the Standard meets market expectations, and are expecting to release the revised documentation on September 4th, 2023."

The public consultation received feedback from numerous stakeholders, including project developers, academics, NGOs and corporate end-buyers. The responses helped shape key changes to the Standard, including:

To dive deeper into all of the major changes made to the Standard, visit ers.org.

Participate in the official launch of the Ecosystem Restoration Standard in September. Follow the ERS Linkedin Page to learn more.

About the Company

The Ecosystem Restoration Standard is a certification for nature-based restoration projects on the Voluntary Carbon Markets. It is designed to empower restoration efforts that combat climate change, uplift biodiversity, and improve livelihoods.

By integrating next-generation dMRV (Digital Monitoring, Reporting & Verification) into the Standard, ERS is able to continuously track progress across multiple baselines, providing greater traceability and transparency for project developers and buyers.

Key Figures & Facts

Press Contacts


Communication Coordinator

[email protected]

+33 (0)6 52 94 83 18

Thibault SORRET

Co-Founder and CEO

[email protected]

+33 (0)6 46 34 35 64


These press releases may also interest you

at 07:53
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Mr. Al Moghaddam has been appointed to the newly created role of Chief Development Officer ("CDO") and consequently he is stepping down from the...

at 07:45
Avicanna Inc. ("Avicanna" or "Company) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce Aras Azadian CEO of Avicanna will be delivering...

at 07:44
Capital Rx, the full-service pharmacy benefit manager ('PBM') and pharmacy benefit administrator ('PBA') advancing our nation's electronic healthcare infrastructure to improve drug price visibility and patient outcomes, today announced that Antonio...

at 07:40
InteliChart, an award-winning provider of patient engagement solutions, is proud to announce it has been named the #1 Patient Engagement and Consumer Outreach Platform by Black Book Market Research for the second consecutive year. This accolade...

at 07:35
Arch Biopartners Inc., ("Arch" or the "Company") , announced today that the University of Calgary's Conjoint Health Research Ethics Board (CHREB) has approved the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac...

at 07:30
Talkiatry, a leading provider of high-quality,...

News published on and distributed by: